Our cells rely on a steady supply of oxygenated blood, delivered by the arteries and capillaries. But the build-up of sticky plaques can cause the arteries to narrow, restricting blood flow. In some people, this starves the limbs of blood, leading to a serious condition called critical limb ischaemia that kills more than half of those affected within 5 years of diagnosis. Although blocked arteries can sometimes be cleared through surgery, for many patients, the only option is amputation to remove the affected limb. This animation explores gene and cell-based therapies that aim to stimulate the growth of new blood vessels, revitalizing blood-starved tissues and helping to avoid the need for amputation. For a poster on this subject go to: http://www.nature.com/critical-limb-ischaemia Nature Research has full responsibility for all editorial content, including Nature Video content. This content is editorially independent of sponsors.
All of the cells in our body require a constant healthy stream of oxygen-rich blood.
But risk factors like smoking, ageing and a poor diet can cause severe problems in our arteries.
They can become clogged up with sticky plaques made of fat, cholesterol and other nasty deposits.
This causes the arteries to harden and narrow,
reducing the blood flow and starving the limbs of oxygenated blood.
Doctors call severe cases critical limb ischemia
and it kills half of its victims within five years.
The worst affected areas are usually the toes and feet, and it isn't pretty.
It can cause burning pain, skin ulcers and gangrene, confining people to their beds.
The standard treatment is surgery to remove the blockage,
using lasers or cutters to destroy the deposits,
or miniature balloons to expand the narrowed arteries.
Or bypass surgery to give the blood a different route around the blockage.
But some blockages occur in hard-to-reach places,
or the patient is just too unwell for an invasive procedure.
In fact, almost a third of sufferers of critical limb ischemia have no options for treatment,
and most of those patients end up needing to have their limb amputated.
But there could be another way.
New research might be able to restore the supply of blood to deprived limbs
by encouraging new blood vessels to grow.
The first is gene therapy.
By inserting genes that promote blood vessel growth into a virus,
and delivering this to the cells that form the inner walls of the arteries,
researchers hope to stimulate new blood vessels to grow around the blockage
and into the oxygen-starved sites.
Although this therapy has helped wound healing,
it hasn't yet reduced the time between CLI diagnosis and amputation in clinical trials.
A more promising option is to extract special cells from the patient's bone marrow,
or peripheral blood, and inject these into the affected areas.
Amongst these cells are the immature blood vessel cells,
called endothelial progenitor cells, or EPCs.
Researchers hope that these cells will migrate to damaged tissues and blockages,
and trigger the growth of new blood vessels.
Early clinical trials have shown cell therapies like this to be safe and effective for wound healing,
but have not yet reduced the likelihood of amputation.
To get better results, researchers are trying to increase the concentration of EPCs.
Doing this in early trials has reduced pain and increased the distance that patients can walk.
If doctors can regrow the blood vessels and revitalise blood-starved tissues,
then they might just be able to savour patients' life and limb.